These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 822138)

  • 41. Bone accumulation of 99mTc-labeled leucocytes.
    Bagwe BA; Sharma SM
    J Nucl Med; 1976 Apr; 17(4):313-6. PubMed ID: 1255260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Splenic imaging with 99mTc-labeled erythrocytes: a comparative study of cell-damaging methods.
    Hamilton RG; Alderson PO; Harwig JF; Siegel BA
    J Nucl Med; 1976 Dec; 17(12):1038-43. PubMed ID: 993833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of two new [99mTc]Tc-HEDP preparations that can be expected to give a better lesion-to-normal-bone uptake ratio when used as bone scanning agents.
    de Ligny CL; Gelsema WJ; Hoevelaken TP; Schuring J
    Nucl Med Biol; 1993 Jan; 20(1):23-9. PubMed ID: 8461877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A critical evaluation of 99mTc-Fe-ascorbic acid complex as a renal scanning agent.
    Winston MA; Halpern SE; Weiss ER; Endow JS; Blahd WH
    J Nucl Med; 1971 Apr; 12(4):171-5. PubMed ID: 5550096
    [No Abstract]   [Full Text] [Related]  

  • 45. In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent.
    Harwig SS; Harwig JF; Coleman RE; Welch MJ
    J Nucl Med; 1976 Jan; 17(1):40-6. PubMed ID: 1244446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic copolymer kit for radionuclide blood-pool imaging.
    Bogdanov AA; Callahan RJ; Wilkinson RA; Martin C; Cameron JA; Fischman AJ; Brady TJ; Weissleder R
    J Nucl Med; 1994 Nov; 35(11):1880-6. PubMed ID: 7965173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scan analysis in myocardial infarction.
    Ell PJ
    Nuklearmedizin; 1976 Aug; 15(4):157-9. PubMed ID: 824624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimization of the ratio of stannous tin: ethane-1-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate.
    Tofe AJ; Francis MD
    J Nucl Med; 1974 Feb; 15(2):69-74. PubMed ID: 4810592
    [No Abstract]   [Full Text] [Related]  

  • 49. A simple "electrolytic" preparation of a 99mTc(Sn)-citrate renal scanning agent.
    Schneider PB
    J Nucl Med; 1973 Nov; 14(11):843-5. PubMed ID: 4743043
    [No Abstract]   [Full Text] [Related]  

  • 50. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
    Kroesbergen J; Gelsema WJ; De Ligny CL
    Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Modified biological behaviour of 99mTc-pertechnetate in man as a result of a preceeding administration of tin (tin effect) (author's transl)].
    Fueger GF; Weinhardt B; Thalhamer M; Sager WD
    Nuklearmedizin; 1978 Mar; 17(1):9-15. PubMed ID: 643631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of formulation conditions on the distribution of 99mTc(NaBH4)-HEDP components separated by anion exchange HPLC.
    Zodda JP; Tanabe S; Heineman WR; Deutsch E
    Int J Rad Appl Instrum A; 1986; 37(4):345-54. PubMed ID: 3021657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP.
    de Groot GJ; Das HA; de Ligny CL
    Int J Rad Appl Instrum A; 1986; 37(6):487-90. PubMed ID: 3019948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding of the bone-seeking agent 99mTc-1-hydroxyethylidene-1,1-diphosphonic acid to cartilage and collagen in vitro and its stimulation by Er3+ and low pH.
    Evans CH; Mears DC
    Calcif Tissue Int; 1980; 32(2):91-4. PubMed ID: 6773636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural characterization of a bridged 99Tc-Sn-dimethylglyoxime complex: implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn (II) reduction of pertechnetate.
    Deutsch E; Elder RC; Lange BA; Vaal MJ; Lay DG
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4287-9. PubMed ID: 1069984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of DMSO treatment on the performance of [99mTc]HEDP.
    Bugaj JE; Esser PD; Tofe AJ; Borgia AT; Fawwaz RA
    Int J Nucl Med Biol; 1984; 11(2):109-11. PubMed ID: 6434460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
    Fogelman I; Greig WR; Bessent RG; Boyle IT
    J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
    [No Abstract]   [Full Text] [Related]  

  • 58. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
    Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
    Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-dependent characteristics of Sn-complexes for preparing 99mTc-labelled radiopharmaceuticals and their bioavailabilities--a review.
    Noronha OP
    Nuklearmedizin; 1978 Jul; 17(3):110-25. PubMed ID: 704364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered 99mTc-pertechnetate distribution in a thyroid scan after 99mTc-Sn pyrophosphate administration.
    Montelibano EB; Ford DR; Sayle BA
    Clin Nucl Med; 1979 Jul; 4(7):277-82. PubMed ID: 223800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.